EVALUATION OF THE EFFECTIVENESS OF RISK MINIMISATION MEASURES: A SURVEY AMONG HEALTH CARE PROFESSIONALS AND PATIENT/CAREGIVERS TO ASSESS THEIR KNOWLEDGE AND ATTITUDES ON PRESCRIBING AND HOME ADMINISTRATION CONDITIONS OF VELAGLUCERASE ALPHA (VPRIVĀ®) IN 6 EUROPEAN COUNTRIES (VPRIV Home infusion)

20/07/2016
19/09/2017
EU PAS number:
EUPAS14255
Study
Planned
Documents
Study protocol
Study results
Study report
Other information